If you made any changes in Pure these will be visible here soon.

Network

Mark Jit

  • London School of Hygiene and Tropical Medicine/Public Health England (PHE)
  • London Sch Hyg & Trop Med & Publ Hlth, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol

External person

Raymond C. W. Hutubessy

  • Initiative for Vaccine Research
  • Initiat Vaccine Res
  • World Hlth Org, World Health Organization, Stop TB Dept
  • WHO, World Health Organization, Immunizat Vaccines & Biolog Dept

External person

Josephine Mauskopf

  • RTI Hlth Int
  • RTI Health International
  • RTI Hlth Solut, Research Triangle Institute

External person

Olivier Ethgen

  • GSK Vaccines, Hlth Econ Dept
  • Health Economics Department
  • University of Liège

External person

Anthony J. Culyer

  • Univ York, University of York - UK, York Management Sch

External person

Johan L. Severens

  • Erasmus Univ, Erasmus University Rotterdam, Inst Hlth Policy & Management
  • Maastricht Univ, Maastricht University, Dept Hlth Org Policy & Econ, Sch Publ Hlth & Primary Care CAPHRI
  • Maastricht University Medical Center
  • Department of Health Organization, Politics and Economics
  • Maastricht Univ, Maastricht University, Dept Hlth Org Policy & Econ
  • Acad Hosp Maastricht, Maastricht University, Dept Clin Epidemiol & Med Technol Assessment
  • Institute for Medical Technology Assessment and Institute of Health Policy and Management, Erasmus University Rotterdam
  • Erasmus Univ, Erasmus University Rotterdam, Inst Hlth Policy & Management IBMG
  • Institute for Medical Technology Assessment (IMTA)
  • Erasmus Univ, Erasmus University Rotterdam, Fac Med
  • Erasmus University Rotterdam
  • Erasmus Univ, Erasmus University Rotterdam, Erasmus Sch Hlth Policy & Management, Dept Hlth Technol Assessment
  • Erasmus Univ, Erasmus University Rotterdam, Inst Hlth Policy & Management, iMTA Inst Med Technol Assessment

External person

Rachel Emerson

  • GlaxoSmithKline Vaccines, GlaxoSmithKline, Emerson Consulting
  • Emerson Consulting

External person

Desmond Curran

  • Health Economics Department
  • GlaxoSmithKline Vaccines, Health Economics Department

External person

Louis P. Garrison

  • Univ Washington, University of Washington Seattle, University of Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Dept Pharm
  • University of Washington

External person

Paul Revill

  • Univ York, University of York - UK, Ctr Hlth Econ

External person